IDPC

IDPC Publications

A key role and added value of IDPC is the production of policy analysis for a broad range of audiences including academia, civil society and policy makers. The majority of these publications are collaborations with members and partners, and are translated into multiple languages to support and facilitate advocacy.

Results 205 to 216 of 453
4 October 2015
Q&A: The death penalty and drug offenses

Q&A: The death penalty and drug offenses

This Q&A was prepared by Harm Reduction International, the International Drug Policy Consortium and the World Coalition Against the Death Penalty ahead of World Day against the Death Penalty on 10 October 2015.
8 September 2015
Реформа наркополитики как ключевой компонент отклика на эпидемию ВИЧ инфекции. Информация для заявителей и получателей грантов

Реформа наркополитики как ключевой компонент отклика на эпидемию ВИЧ инфекции. Информация для заявителей и получателей грантов

Этот брифинг предназначена для поддержки тех, кто участвует в разработке приложений для грантов в Глобальный фонд , направленных на содействие всестороннему и эффективных ответов на ВИЧ.
1 September 2015
Asia: Advocating for humane and effective drug policies

Asia: Advocating for humane and effective drug policies

Gloria Lai, IDPC Senior Policy Officer, argues that civil society must advocate for, and help facilitate, a more open and rational dialogue with governments to encourage them to engage in an honest assessment of the current drug control approach in Asia.
17 August 2015
Media workshop on drug policy in West Africa

Media workshop on drug policy in West Africa

This workshop raised awareness and understanding of the nature of the drug problem in West Africa and called on the media to collaborate with civil society organisations to end the effects of bad drug policies on human rights and public health.
14 August 2015
The post-2015 drug strategy for ASEAN: Towards a new paradigm in drug policy?

The post-2015 drug strategy for ASEAN: Towards a new paradigm in drug policy?

This IDPC advocacy note offers analysis and recommendations to contribute to the development of a post- 2015 ASEAN drug strategy that can meet the expectations of the ASEAN Secretary-General in being innovative, prompt to adapt to changing and challenging circumstances, and global in its outlook.